Unknown

Dataset Information

0

Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospects.

ABSTRACT: A number of novel oral agents are now approved for use in relapsing multiple sclerosis (MS). Among these agents, teriflunomide has shown promise with respect to clinical efficacy and safety in relapsing MS patients. In this review we aim to clarify the role of teriflunomide in the context of current and emerging MS treatment options by summarizing relevant points on the use of teriflunomide in MS, with a discussion of teriflunomide's pharmacologic properties, pivotal clinical trials, and safety and tolerability.

SUBMITTER: Oh J 

PROVIDER: S-EPMC4206621 | biostudies-literature | 2014 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospects.

Oh Jiwon J   O'Connor Paul W PW  

Therapeutic advances in neurological disorders 20140901 5

A number of novel oral agents are now approved for use in relapsing multiple sclerosis (MS). Among these agents, teriflunomide has shown promise with respect to clinical efficacy and safety in relapsing MS patients. In this review we aim to clarify the role of teriflunomide in the context of current and emerging MS treatment options by summarizing relevant points on the use of teriflunomide in MS, with a discussion of teriflunomide's pharmacologic properties, pivotal clinical trials, and safety  ...[more]

Similar Datasets

Unknown The potential role for ocrelizumab in the treatment of multiple sclerosis: current evidence and future prospects.
| S-EPMC4710102 | biostudies-literature
Unknown An update of teriflunomide for treatment of multiple sclerosis.
| S-EPMC3673963 | biostudies-literature
Unknown Current and Future Immunotherapies for Multiple Sclerosis.
| S-EPMC8343631 | biostudies-literature
Unknown Oral teriflunomide in the treatment of relapsing forms of multiple sclerosis: clinical evidence and long-term experience.
| S-EPMC5703103 | biostudies-literature
Unknown Treatment of cutaneous melanoma: current approaches and future prospects.
| S-EPMC3004577 | biostudies-other
Unknown Teriflunomide Treatment of Multiple Sclerosis Selectively Modulates CD8 Memory T Cells.
| S-EPMC8552527 | biostudies-literature
Unknown Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis.
| S-EPMC4720678 | biostudies-literature
Unknown Pharmacogenetic Biomarkers to Predict Treatment Response in Multiple Sclerosis: Current and Future Perspectives.
| S-EPMC5540248 | biostudies-literature
Unknown Teriflunomide in relapsing multiple sclerosis: therapeutic utility.
| S-EPMC3752181 | biostudies-literature
Unknown Oxidative Stress in Preterm Infants: Overview of Current Evidence and Future Prospects.
| S-EPMC7408528 | biostudies-literature